Published in Ther Adv Cardiovasc Dis on August 01, 2008
Cardiovascular Risk in Infants Exposed to Pre-eclampsia in Utero | NCT05091827
Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension (2010) 1.59
Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol (2013) 1.57
The role of aspirin in women's health. Int J Womens Health (2011) 1.39
Hypertension in pregnancy as a risk factor for cardiovascular disease later in life. J Hypertens (2010) 1.36
Placental ischemia and cardiovascular dysfunction in preeclampsia and beyond: making the connections. Expert Rev Cardiovasc Ther (2008) 0.94
Identification of ACOX2 as a shared genetic risk factor for preeclampsia and cardiovascular disease. Eur J Hum Genet (2011) 0.93
Metabolomic biomarkers in serum and urine in women with preeclampsia. PLoS One (2014) 0.92
Physicians' knowledge of future vascular disease in women with preeclampsia. Hypertens Pregnancy (2011) 0.92
Exposure to experimental preeclampsia in mice enhances the vascular response to future injury. Hypertension (2015) 0.92
Maternal serum levels of TNF-alpha and IL-6 long after delivery in preeclamptic and normotensive pregnant women. Mediators Inflamm (2010) 0.84
Mechanisms and management of hypertension in pregnant women. Curr Hypertens Rep (2011) 0.82
Hypertension after preeclampsia and relation to the C1114G polymorphism (rs4606) in RGS2: data from the Norwegian HUNT2 study. BMC Med Genet (2014) 0.80
Preeclampsia and the future risk of hypertension: the pregnant evidence. Curr Hypertens Rep (2013) 0.80
Pregnancy induces persistent changes in vascular compliance in primiparous women. Am J Obstet Gynecol (2015) 0.80
Exposure to AT1 receptor autoantibodies during pregnancy increases susceptibility of the maternal heart to postpartum ischemia-reperfusion injury in rats. Int J Mol Sci (2014) 0.79
Renal evaluation in women with preeclampsia. Nephron Extra (2012) 0.79
Left ventricular hypertrophy after hypertensive pregnancy disorders. Heart (2015) 0.78
Placental growth factor influences maternal cardiovascular adaptation to pregnancy in mice. Biol Reprod (2014) 0.77
Maternal and cord steroid sex hormones, angiogenic factors, and insulin-like growth factor axis in African-American preeclamptic and uncomplicated pregnancies. Cancer Causes Control (2012) 0.76
Lipoprotein-associated phospholipase A2 is associated with postpartum hypertension in women with history of preeclampsia. Heart Vessels (2014) 0.76
Pregnancy-Associated Hypertension in Glucose-Intolerant Pregnancy and Subsequent Metabolic Syndrome. Obstet Gynecol (2016) 0.76
The Norwegian preeclampsia family cohort study: a new resource for investigating genetic aspects and heritability of preeclampsia and related phenotypes. BMC Pregnancy Childbirth (2015) 0.75
The relationship of a family history for hypertension, myocardial infarction, or stroke with cardiovascular physiology in young women. Reprod Sci (2013) 0.75
Health workers' knowledge on future vascular disease risk in women with pre-eclampsia in south western Nigeria. BMC Res Notes (2015) 0.75
Pregnancies After the Diagnosis of Mild Gestational Diabetes Mellitus and Risk of Cardiometabolic Disorders. Obstet Gynecol (2017) 0.75
LDH (Lactate Dehydrogenase): A Biochemical Marker for the Prediction of Adverse Outcomes in Pre-eclampsia and Eclampsia. J Obstet Gynaecol India (2014) 0.75
Analysis of maternal and fetal cardiovascular systems during hyperglycemic pregnancy in the nonobese diabetic mouse. Biol Reprod (2013) 0.75
Deficiency in catechol-o-methyltransferase is linked to a disruption of glucose homeostasis in mice. Sci Rep (2017) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (1993) 27.07
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest (2003) 13.72
Fetal origins of coronary heart disease. BMJ (1995) 11.27
Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol (2000) 11.11
Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ (2007) 6.73
Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet (1999) 6.69
Vitamin E consumption and the risk of coronary disease in women. N Engl J Med (1993) 5.39
Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet (2001) 5.28
Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet (2006) 5.26
Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ (2001) 4.24
Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation (2001) 3.57
Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol (1998) 3.37
Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ (2003) 2.88
Platelet activation in obese women: role of inflammation and oxidant stress. JAMA (2002) 2.79
Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet (2005) 2.76
Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol (1997) 2.66
Leptin: the tale of an obesity gene. Diabetes (1996) 2.37
Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol (2001) 2.22
Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol (1986) 2.21
Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol (1995) 2.19
Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. Circulation (1997) 2.17
Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process. Hum Reprod (1999) 2.09
Risk factors for myocardial infarction in young women. Br J Prev Soc Med (1976) 2.01
Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol (1995) 1.92
Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension (2004) 1.92
Birth weight of offspring and mortality in the Renfrew and Paisley study: prospective observational study. BMJ (1997) 1.85
Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol (1997) 1.59
Cardiovascular sequelae of toxaemia of pregnancy. Heart (1997) 1.54
Hypertension in pregnancy: an emerging risk factor for cardiovascular disease. Nat Clin Pract Nephrol (2007) 1.54
Pregnancy in women with Type 2 diabetes: 12 years outcome data 1990-2002. Diabet Med (2003) 1.50
Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol (2000) 1.48
Relation between infants' birth weight and mothers' mortality: prospective observational study. BMJ (2000) 1.46
Long-term mortality after preeclampsia. Epidemiology (2005) 1.44
Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. BMJ (1995) 1.43
Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. J Clin Endocrinol Metab (1997) 1.39
Homocysteine and coronary atherosclerosis. J Am Coll Cardiol (1996) 1.39
Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand (1995) 1.38
Long-term effect of preeclampsia on blood-pressure. Lancet (1961) 1.36
Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol (2001) 1.33
Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol (1994) 1.33
The risk of maternal ischaemic heart disease after gestational hypertensive disease. BJOG (2005) 1.27
A study of the long-term effects of pre-eclampsia on blood pressue and renal function. J Obstet Gynaecol Br Commonw (1974) 1.23
Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet Gynecol (1983) 1.16
Cardiovascular death in women who had hypertension in pregnancy: a case-control study. BJOG (2005) 1.16
Preeclampsia as a risk factor for cardiovascular disease later in life: validation of a preeclampsia questionnaire. Am J Obstet Gynecol (2008) 1.16
Thrombophilia and pregnancy. Reprod Biol Endocrinol (2003) 1.16
Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide (2000) 1.12
Preeclampsia and the risk of ischemic stroke among young women: results from the Stroke Prevention in Young Women Study. Stroke (2006) 1.11
Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol (1997) 1.09
Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia. Metabolism (1998) 1.07
Long term follow-up of women with hypertension in pregnancy. Int J Gynaecol Obstet (1988) 1.07
The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. Metabolism (1993) 1.02
Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in preeclampsia. Eur J Obstet Gynecol Reprod Biol (1997) 1.01
Cardiovascular and thromboembolic events following hypertensive pregnancy. Am J Kidney Dis (2003) 0.99
Mechanisms of oxidation, antioxidants, and atherosclerosis. Curr Opin Lipidol (1994) 0.98
Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Obstet Gynecol (1995) 0.95
Lipoprotein atherogenicity: an overview of current mechanisms. Proc Nutr Soc (1999) 0.94
Free leptin is increased in normal pregnancy and further increased in preeclampsia. Metabolism (2000) 0.93
Insulin resistance syndrome in preeclampsia. Semin Reprod Endocrinol (1998) 0.92
Lipid peroxidation and antioxidants in normal and pre-eclamptic pregnancies. Placenta (1996) 0.90
Increased ascorbate radical formation and ascorbate depletion in plasma from women with preeclampsia: implications for oxidative stress. Free Radic Biol Med (1997) 0.89
Soluble Flt-1 as a diagnostic marker of pre-eclampsia. Aust N Z J Obstet Gynaecol (2008) 0.89
Neutrophil activation is confined to the maternal circulation in pregnancy-induced hypertension. Obstet Gynecol (1991) 0.89
Plasma P selectin (GMP-140) and glycocalicin are elevated in preeclampsia and eclampsia: their significances. Am J Obstet Gynecol (1996) 0.87
Homocysteine and cellular fibronectin are increased in preeclampsia, not transient hypertension of pregnancy. Hypertens Pregnancy (2001) 0.87
Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol (2000) 0.85
The neutrophil and preeclampsia. Semin Reprod Endocrinol (1998) 0.85
Thrombomodulin, plasminogen activator inhibitor type 1 (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia. Int J Gynaecol Obstet (1996) 0.85
Recognition of the long-term sequelae of eclampsia. Am J Obstet Gynecol (2000) 0.84
Fibronectin is a marker for organ involvement and may reflect the severity of preeclampsia. Hypertens Pregnancy (2001) 0.82
Is cellular fibronectin a biological marker for pre-eclampsia? Eur J Obstet Gynecol Reprod Biol (2001) 0.81
Clotting inhibitors and fibronectin as potential markers in preeclampsia. Int J Gynaecol Obstet (1994) 0.78
American Journal of Obstetrics and Gynecology, Volume 124, 1976: The remote prognosis of eclamptic women. Sixth periodic report. Am J Obstet Gynecol (2000) 0.77
Risk factors for acute myocardial infarction in women. BMJ (1989) 0.77
Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis. Nephrol Dial Transplant (2009) 2.41
Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates. Transplantation (2013) 2.10
Batch effect correction for genome-wide methylation data with Illumina Infinium platform. BMC Med Genomics (2011) 1.84
Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study. Hypertension (2013) 1.76
A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol (2010) 1.70
Preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk. Clin Cardiol (2012) 1.62
Hypertension in pregnancy is a risk factor for microalbuminuria later in life. J Clin Hypertens (Greenwich) (2013) 1.48
Page kidney: etiology, renal function outcomes and risk for future hypertension. J Clin Hypertens (Greenwich) (2012) 1.43
Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis: clinical and histopathological correlates. Nephrol Dial Transplant (2010) 1.28
Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension. Am J Physiol Renal Physiol (2009) 1.27
Posterior reversible encephalopathy syndrome and eclampsia: pressing the case for more aggressive blood pressure control. Mayo Clin Proc (2011) 1.20
Preeclampsia as a risk factor for cardiovascular disease later in life: validation of a preeclampsia questionnaire. Am J Obstet Gynecol (2008) 1.16
Contrast nephropathy after coronary angiography. Mayo Clin Proc (2004) 1.16
VEGF inhibition, hypertension, and renal toxicity. Curr Oncol Rep (2012) 1.10
Contrast-induced nephropathy and its prevention: What do we really know from evidence-based findings? J Nephrol (2009) 1.09
Acute kidney injury following total joint arthroplasty: retrospective analysis. Can J Anaesth (2012) 1.09
T-cell receptor transgenic response to an endogenous polymorphic autoantigen determines susceptibility to diabetes. Diabetes (2004) 1.04
TGF expression and macrophage accumulation in atherosclerotic renal artery stenosis. Clin J Am Soc Nephrol (2012) 1.04
Hypertension in pregnancy is associated with elevated homocysteine levels later in life. Am J Obstet Gynecol (2013) 0.98
Dietary sodium restriction and beta2-adrenergic receptor polymorphism modulate cardiovascular function in humans. J Physiol (2006) 0.98
Hypertensive pregnancy disorders: current concepts. J Clin Hypertens (Greenwich) (2007) 0.96
Obstetric nephrology: lupus and lupus nephritis in pregnancy. Clin J Am Soc Nephrol (2012) 0.96
Inhibition of p38 MAPK attenuates renal atrophy and fibrosis in a murine renal artery stenosis model. Am J Physiol Renal Physiol (2013) 0.94
Kidney injury during pregnancy: associated comorbid conditions and outcomes. Arch Gynecol Obstet (2012) 0.93
Revisiting the role of nephrectomy for advanced renovascular disease. Am J Med (2003) 0.89
Acute renal failure in a young weight lifter taking multiple food supplements, including creatine monohydrate. J Ren Nutr (2006) 0.88
Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes. Nephrol Dial Transplant (2008) 0.88
Hypertension in pregnancy is a risk factor for peripheral arterial disease decades after pregnancy. Atherosclerosis (2013) 0.86
Adverse outcomes of renovascular hypertension during pregnancy. Nat Clin Pract Nephrol (2006) 0.86
The treatment of hypertension during pregnancy: when should blood pressure medications be started? Curr Cardiol Rep (2013) 0.86
Advances in the pathophysiology of preeclampsia and related podocyte injury. Kidney Int (2014) 0.85
Incidence and prognosis of acute heart failure in the thrombotic microangiopathies. Am J Med (2005) 0.85
Women, kidney disease, and pregnancy. Adv Chronic Kidney Dis (2013) 0.84
Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause. Biol Sex Differ (2013) 0.83
Pre-eclamptic pregnancies: an opportunity to identify women at risk for future cardiovascular disease. Womens Health (Lond Engl) (2008) 0.83
Distributed feedback diode laser spectrometer at 2.7 microm for sensitive, spatially resolved H2O vapor detection. Appl Opt (2009) 0.83
Hypertension during pregnancy is associated with coronary artery calcium independent of renal function. J Womens Health (Larchmt) (2009) 0.83
Mechanisms and management of hypertension in pregnant women. Curr Hypertens Rep (2011) 0.82
Hypertension in pregnancy: is it time for a new approach to treatment? J Hypertens (2012) 0.82
From placenta to podocyte: vascular and podocyte pathophysiology in preeclampsia. Clin Nephrol (2012) 0.82
Hypertension in pregnancy is associated with elevated C-reactive protein levels later in life. J Hypertens (2013) 0.82
Genome-wide methylation profiling demonstrates hypermethylation in maternal leukocyte DNA in preeclamptic compared to normotensive pregnancies. Hypertens Pregnancy (2013) 0.81
Normal early pregnancy: a transient state of epigenetic change favoring hypomethylation. Epigenetics (2012) 0.81
Long-term follow-up of renal function and blood pressure after selective renal arterial embolization. Perspect Vasc Surg Endovasc Ther (2010) 0.80
The management of hypertension in pregnancy. Adv Chronic Kidney Dis (2013) 0.80
Drug treatment of hypertension in pregnancy. Drugs (2014) 0.79
Acute kidney injury in the pregnant patient. Clin Nephrol (2012) 0.79
The role of angiogenic factors in the prediction and diagnosis of preeclampsia superimposed on chronic hypertension. Hypertension (2012) 0.78
Quantifying the Increase in Radiation Exposure Associated with SPECT/CT Compared to SPECT Alone for Routine Nuclear Medicine Examinations. Int J Mol Imaging (2011) 0.77
Restenosis following percutaneous renal artery revascularization. Nephron Clin Pract (2007) 0.77
Pre-eclampsia and maternal placental syndromes: an indicator or cause of long-term cardiovascular disease? Heart (2012) 0.77
Molecular phylogeny and genetic identification of populations of two species of Feirana frogs (Amphibia: Anura, Ranidae, Dicroglossinae, Paini) endemic to China. Zoolog Sci (2009) 0.76
Acute Interstitial Nephritis Proteinuria and Herpes Simplex Virus Hepatitis in Pregnancy Mimic HELLP Syndrome (Hemolysis, Elevated Liver Enzymes, Low Platelets). AJP Rep (2011) 0.75
Correction: From Static to Interactive: Transforming Data Visualization to Improve Transparency. PLoS Biol (2016) 0.75
25-year-old man with flank pain, hematuria, and proteinuria. Mayo Clin Proc (2009) 0.75
38-year old woman with hypertension, headaches, and abdominal bruit. Mayo Clin Proc (2010) 0.75
Hypertension during pregnancy is associated with increased risk of chronic and end-stage kidney disease. Evid Based Nurs (2013) 0.75
Urinary podocyte excretion and proteinuria in patients treated with antivascular endothelial growth factor therapy for solid tumor malignancies. Oncology (2014) 0.75
Teaching quality essentials: the effectiveness of a team-based quality improvement curriculum in a tertiary health care institution. Am J Med Qual (2012) 0.75
Development and metrological characterization of a tunable diode laser absorption spectroscopy (TDLAS) spectrometer for simultaneous absolute measurement of carbon dioxide and water vapor. Appl Spectrosc (2015) 0.75
Post-traumatic haemodialysis catheter fracture with bacteraemia. Nephrol Dial Transplant (2003) 0.75
Acute kidney injury in patients with inactive cytochrome P450 polymorphisms. Ren Fail (2009) 0.75
Broadband supercontinuum laser absorption spectrometer for multiparameter gas phase combustion diagnostics. Opt Lett (2015) 0.75
Renal vascular disease: a vexing challenge for the clinician. Prog Cardiovasc Dis (2009) 0.75
Novel time-of-flight fiber dispersion measurement technique using supercontinuum light sources and acousto-optical tunable filters. Appl Opt (2015) 0.75
23-year-old man with hypertension and flank trauma. Mayo Clin Proc (2002) 0.75
Influence of preeclampsia and late-life hypertension on MRI measures of cortical atrophy. J Hypertens (2017) 0.75
Method of diagnosing pre-eclampsia. Expert Opin Med Diagn (2007) 0.75
Ammonia concentration distribution measurements in the exhaust of a heavy duty diesel engine based on limited data absorption tomography. Opt Express (2017) 0.75
The role of type I hypersensitivity reaction and IgE-mediated mast cell activation in acute interstitial nephritis. Clin Nephrol (2015) 0.75
63-year-old man with chronic hepatitis C virus infection and proteinuria. Mayo Clin Proc (2013) 0.75